You have entered the IISP: Interactive Information System on Pathogenomics
If you would like to insert information about your research or research group, please click to the following link to download the form. After filling it out, please send back to email@example.com or firstname.lastname@example.org.
Here you will find information about Research groups in the PathoGenoMics fields from the ERA-NET partner countries (Austria, Finland, France, Hungary, Israel, Latvia, Portugal, Slovenia and Spain).
This information is supposed to support cooperation between researchers from different European countries
and thus enhance the development of a European Research Area for PathoGenoMics .
The following information is available and can be searched for:
- researcher names
- Institution of the respective researcher, city and country of his/her institution
- Contact data of the researcher (address, phone, email)
- Research topics and studied microorganisms of the researcher
- Special techniques applied by the researcher
- Potential cooperation topics suggested by the researcher
If you have any comments/questions or if you would like to add some information, please contact email@example.com
|Name:||Dr. Nagy, Gábor|
|Address:||Szigeti str. 12.|
|Institution:||Dept. of Medical Microbiology and Immunology|
|Our aim is to develop live attenuated vaccine candidates of enteric bacteria. Primarily, we test rfaH mutants which exhibit the so-called “gently rough” phenotype. These mutants show characteristics of deep-rough LPS mutants, however, they retain some O-antigens. This pattern of LPS down-regulation makes these mutants capable of eliciting a cross-protective immune response. Animal models are used for the assessment of the immune response elicited as well as for vaccination experiments. The conserved protein antigens that are responsible for the cross-reactivity are to be identified by serological and proteomics methods.|
|Special methods / technologies:|
|Mutagenesis, in vivo virulence tests, phenotypic tests, microarrays, serologic tests|
|Suggestions for potential research cooperations:|